Cyramza (ramucirumab)

pCPA File Number: 20850

Negotiation Status:

Concluded with an LOI

Indication(s):

Advanced or Metastatic Gastric Cancer or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Sponsor/Manufacturer:

Eli Lilly Canada Inc.

CDA-AMC Project Number:

PC0059-000

pCPA Engagement Letter Issued:

2015-11-12

Negotiation Process Concluded:

2016-10-27